Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MYRIAD GENETICS INC Director's Dealing 2024

Dec 10, 2024

32566_dirs_2024-12-10_e6bdd80c-4e97-43fe-9b7c-be74a74f0ded.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2024-12-10

Reporting Person: Davis Mark Steven (Director)

More from MYRIAD GENETICS INC

Interim / Quarterly Report 2026
May 6
Regulatory Filings 2026
May 5
Annual Report 2026
Apr 14
Proxy Solicitation & Information Statement 2026
Apr 14
Proxy Solicitation & Information Statement 2026
Apr 14
Major Shareholding Notification 2026
Apr 7
Major Shareholding Notification 2026
Mar 27
Regulatory Filings 2026
Mar 5
Regulatory Filings 2026
Mar 4
Director's Dealing 2026
Mar 2
View all filings →